A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer
This study has been withdrawn prior to enrollment.
(Study closed by Protocol Review Monitoring Committee because of lack of accrual)
University of Kansas
First Posted: July 16, 2010
Last Update Posted: October 24, 2012
Information provided by (Responsible Party):
University of Kansas Medical Center ( University of Kansas )
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Study Completion Date:||March 2012|
|Primary Completion Date:||March 2012 (Final data collection date for primary outcome measure)|